ATRA vs OKE · rev $128.9M vs P/E 15, rev $21.70B
Atara Biotherapeutics Inc (ATRA) versus ONEOK Inc (OKE) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
ONEOK Inc (OKE) is a oil & gas midstream company listed on NYSE.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported OKE revenue for 2024-12-31 was $21.70B. Net income was $3.11B. Revenue was up 22.7% from 2023-12-31 to 2024-12-31. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
ATRA currently screens at market cap $87.1M. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
Not investment advice. Open the ATRA and OKE stock pages for the full models.
Not investment advice.